| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
61,249 |
55,167 |
$2.42M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33,178 |
29,474 |
$1.86M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,315 |
13,908 |
$958K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,286 |
15,401 |
$618K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,977 |
2,720 |
$244K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,198 |
2,080 |
$114K |
| 99215 |
Prolong outpt/office vis |
1,226 |
1,114 |
$111K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
836 |
810 |
$75K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,747 |
2,600 |
$74K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
866 |
823 |
$67K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,967 |
2,833 |
$65K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
13,421 |
10,891 |
$62K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,746 |
2,566 |
$31K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,077 |
1,907 |
$27K |
| 99000 |
|
1,660 |
1,561 |
$26K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
833 |
637 |
$26K |
| 36415 |
Collection of venous blood by venipuncture |
11,153 |
9,888 |
$25K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,087 |
1,049 |
$24K |
| 71046 |
Radiologic examination, chest; 2 views |
2,586 |
2,455 |
$22K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,589 |
1,535 |
$21K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
360 |
271 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,165 |
1,116 |
$16K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
705 |
231 |
$16K |
| 0002A |
|
413 |
369 |
$13K |
| 80061 |
Lipid panel |
1,099 |
1,076 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,776 |
1,653 |
$11K |
| 0001A |
|
530 |
471 |
$11K |
| 80053 |
Comprehensive metabolic panel |
1,258 |
1,211 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
142 |
142 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,499 |
1,416 |
$9K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
57 |
57 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
205 |
194 |
$8K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
129 |
122 |
$7K |
| 90686 |
|
885 |
848 |
$7K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
94 |
86 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
905 |
889 |
$7K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
43 |
43 |
$6K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
84 |
80 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
951 |
565 |
$6K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
323 |
310 |
$5K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
89 |
74 |
$5K |
| 85027 |
|
642 |
600 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
203 |
197 |
$4K |
| 95251 |
|
156 |
147 |
$3K |
| 90682 |
|
55 |
55 |
$3K |
| 81001 |
|
1,026 |
965 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
50 |
46 |
$2K |
| 81025 |
|
446 |
422 |
$2K |
| 87088 |
|
314 |
299 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
114 |
107 |
$2K |
| 87631 |
|
13 |
13 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
30 |
26 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
33 |
31 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
611 |
583 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27 |
26 |
$1K |
| 99310 |
Prolong nursin fac eval 15m |
16 |
14 |
$1K |
| 99307 |
|
59 |
53 |
$1K |
| 99233 |
Prolong inpt eval add15 m |
20 |
12 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
121 |
97 |
$911.62 |
| 90715 |
|
106 |
98 |
$868.89 |
| 71045 |
Radiologic examination, chest; single view |
159 |
140 |
$850.02 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
96 |
91 |
$811.54 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
13 |
12 |
$686.50 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
86 |
83 |
$645.19 |
| 94729 |
|
82 |
81 |
$543.54 |
| 99152 |
|
96 |
66 |
$534.92 |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
21 |
12 |
$524.80 |
| 94726 |
|
42 |
41 |
$424.18 |
| 94060 |
|
42 |
41 |
$336.89 |
| 70450 |
Computed tomography, head or brain; without contrast material |
14 |
12 |
$320.67 |
| 85018 |
|
177 |
164 |
$262.88 |
| 84439 |
|
51 |
50 |
$245.76 |
| 99442 |
|
16 |
13 |
$236.34 |
| 90651 |
|
53 |
50 |
$221.45 |
| 87420 |
|
16 |
16 |
$207.63 |
| 73610 |
|
15 |
14 |
$136.95 |
| 82043 |
|
14 |
14 |
$86.41 |
| 81003 |
|
135 |
128 |
$70.14 |
| 99173 |
|
32 |
31 |
$55.16 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
155 |
133 |
$0.00 |
| 90734 |
|
43 |
39 |
$0.00 |
| 87210 |
|
17 |
15 |
$0.00 |
| 99223 |
Prolong inpt eval add15 m |
20 |
12 |
$0.00 |